Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth B Furgeson

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Cardiovascular Research|January 7, 2010
Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formationSeth B Furgeson, Peter A Simpson, Insun Park, et al.
Molecular Pharmacology|August 30, 2014
Activation of the retinoid X receptor modulates angiotensin II-induced smooth muscle gene expression and inflammation in vascular smooth muscle cellsAllison M B Lehman, John R Montford, Henrick Horita, et al.
Circulation Research|March 15, 2008
Targeted deletion of PTEN in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell-derived factor-1alphaRaphael A Nemenoff, Peter A Simpson, Seth B Furgeson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 19, 2011
SDF-1α induction in mature smooth muscle cells by inactivation of PTEN is a critical mediator of exacerbated injury-induced neointima formationRaphael A Nemenoff, Henrick Horita, Allison C Ostriker, et al.
Journal of Lipid Research|December 13, 2017
Bone marrow-derived cPLA2α contributes to renal fibrosis progressionJohn R Montford, Allison M B Lehman, Colin D Bauer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 20, 2019
PTEN (Phosphatase and Tensin Homolog) Protects Against Ang II (Angiotensin II)-Induced Pathological Vascular Fibrosis and Remodeling-Brief ReportSizhao Lu, Keith A Strand, Marie F Mutryn, et al.
Journal of the American Heart Association|June 4, 2013
Selective inactivation of PTEN in smooth muscle cells synergizes with hypoxia to induce severe pulmonary hypertensionHenrick Horita, Seth B Furgeson, Allison Ostriker, et al.
American Journal of Physiology. Renal Physiology|December 6, 2021
15-Lipoxygenase worsens renal fibrosis, inflammation, and metabolism in a murine model of ureteral obstructionJohn R Montford, Colin Bauer, Jeremy Rahkola, et al.
JCI Insight|February 23, 2018
PTEN deficiency promotes pathological vascular remodeling of human coronary arteriesKaren S Moulton, Marcella Li, Keith Strand, et al.
Kidney International|September 26, 2018
CD8<sup>+</sup> T cells modulate autosomal dominant polycystic kidney disease progressionEmily K Kleczko, Kenneth H Marsh, Logan C Tyler, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cardiovascular Research|January 7, 2010
Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formationSeth B Furgeson, Peter A Simpson, Insun Park, et al.
Molecular Pharmacology|August 30, 2014
Activation of the retinoid X receptor modulates angiotensin II-induced smooth muscle gene expression and inflammation in vascular smooth muscle cellsAllison M B Lehman, John R Montford, Henrick Horita, et al.
Circulation Research|March 15, 2008
Targeted deletion of PTEN in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell-derived factor-1alphaRaphael A Nemenoff, Peter A Simpson, Seth B Furgeson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 19, 2011
SDF-1α induction in mature smooth muscle cells by inactivation of PTEN is a critical mediator of exacerbated injury-induced neointima formationRaphael A Nemenoff, Henrick Horita, Allison C Ostriker, et al.
Journal of Lipid Research|December 13, 2017
Bone marrow-derived cPLA2α contributes to renal fibrosis progressionJohn R Montford, Allison M B Lehman, Colin D Bauer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 20, 2019
PTEN (Phosphatase and Tensin Homolog) Protects Against Ang II (Angiotensin II)-Induced Pathological Vascular Fibrosis and Remodeling-Brief ReportSizhao Lu, Keith A Strand, Marie F Mutryn, et al.
Journal of the American Heart Association|June 4, 2013
Selective inactivation of PTEN in smooth muscle cells synergizes with hypoxia to induce severe pulmonary hypertensionHenrick Horita, Seth B Furgeson, Allison Ostriker, et al.
American Journal of Physiology. Renal Physiology|December 6, 2021
15-Lipoxygenase worsens renal fibrosis, inflammation, and metabolism in a murine model of ureteral obstructionJohn R Montford, Colin Bauer, Jeremy Rahkola, et al.
JCI Insight|February 23, 2018
PTEN deficiency promotes pathological vascular remodeling of human coronary arteriesKaren S Moulton, Marcella Li, Keith Strand, et al.
Kidney International|September 26, 2018
CD8<sup>+</sup> T cells modulate autosomal dominant polycystic kidney disease progressionEmily K Kleczko, Kenneth H Marsh, Logan C Tyler, et al.
Pageof 3